<DOC>
	<DOC>NCT01368575</DOC>
	<brief_summary>The primary objective is to estimate surgical treatment (prosthesis or plastic) of moderate and severe ischemic mitral regurgitation combined with CABG in patients with CAD and impact on heart failure and progress of mitral regurgitation.</brief_summary>
	<brief_title>Surgical Treatment of Ischemic Mitral Regurgitation</brief_title>
	<detailed_description />
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Patient is a male or female between 30 to 75 years of age (inclusive) on the day of signing the informed consent. Patients with a verified diagnosis of CAD, including post myocardial infarction scar. Coronary artery pathology to be coronary artery bypasses grafting. The presence of moderate or severe ischemic mitral regurgitation. The patient did not sign the informed consent. Aortic valve disease requiring prosthetic or aortic valve repair. Organic lesion of valve and subvalvular structures (endocarditis and degenerative processes of the mitral valve). а) separation of the mitral valve chords; б) rupture and perforation of the mitral valve; в) myxomatous degeneration and calcification of the mitral valve Patients with acute coronary syndrome. The presence of the indications for angioplasty of the coronary arteries. Coronary artery bypasses grafting in history. Parallel patient participation in other studies. The organs diseases, which can be reason to death after surgery during the first 3 years.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Ischemic</keyword>
	<keyword>Mitral</keyword>
	<keyword>Valve</keyword>
	<keyword>Insufficiency</keyword>
	<keyword>SVR</keyword>
</DOC>